Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin

2002

Background: In vitro, bosentan has been shown to be a mild inducer of cytochrome P450 (CYP) 2C9 and 3A4.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

34

References

7

Citations